Inspira Technologies Oxy B.H.N. Ltd. (IINN) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
2 Ha-Tidhar St.
Ra'anana, 4366504
Israel
Phone
972 9 966 4488
Sector
Healthcare
Industry
Medical - Devices
Employees
39
First IPO Date
July 14, 2021
| Name | Title | Pay | Year Born |
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer & Director | 359,037 | 1976 |
| Daniella Yeheskely-Hayon | Chief Technology Officer | 261,624 | 1977 |
| Yafit Tehila | Chief Financial Officer | 269,693 | 1981 |
| Avi Shabtai | Chief Operating Officer and Vice President of Research & Development | 344,302 | 1974 |
| Adi Shmueli | Director of Marketing | 0 | N/A |
| Sivan Ozeri | Administrative Manager | 0 | N/A |
| Yoav Rozanovich | Chief Business Officer | 0 | N/A |
| Mike Hershkovitz | Vice President of Global Sales | 0 | N/A |
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.